Clinical trial
Study on Precision Dosing Strategies of Anti-infective Agents in the Very Early Stage of Kidney Transplantation
NCT07765615 is registered in ClinicalTrials.gov with Zhongnan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study on Precision Dosing Strategies of Anti-infective Agents in the Very Early Stage of Kidney Transplantation
- Lead sponsor
- Zhongnan Hospital
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- August 25, 2026
- Completion date
- August 31, 2027
- Enrollment
- 40 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
transplant recipient (kidney)